Iterum Therapeutics Correlations
ITRM Stock | USD 1.44 0.01 0.69% |
The current 90-days correlation between Iterum Therapeutics PLC and Tonix Pharmaceuticals Holding is -0.14 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Iterum Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Iterum Therapeutics PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Iterum Therapeutics Correlation With Market
Good diversification
The correlation between Iterum Therapeutics PLC and DJI is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Iterum Therapeutics PLC and DJI in the same portfolio, assuming nothing else is changed.
Iterum |
Moving together with Iterum Stock
0.77 | CDIOW | Cardio Diagnostics | PairCorr |
0.91 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
0.79 | ELVN | Enliven Therapeutics | PairCorr |
0.63 | GPCR | Structure Therapeutics | PairCorr |
0.94 | ZURA | Zura Bio Limited | PairCorr |
0.83 | IMMX | Immix Biopharma | PairCorr |
0.73 | IMRX | Immuneering Corp | PairCorr |
0.63 | INBX | Inhibrx Symbol Change | PairCorr |
0.88 | MLTX | MoonLake Immunotherapeuti | PairCorr |
0.8 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.84 | PYXS | Pyxis Oncology | PairCorr |
0.75 | SCLX | Scilex Holding | PairCorr |
0.84 | ASMB | Assembly Biosciences Earnings Call Tomorrow | PairCorr |
0.74 | ATNF | 180 Life Sciences | PairCorr |
0.72 | AVTE | Aerovate Therapeutics | PairCorr |
0.71 | BIIB | Biogen Inc | PairCorr |
Moving against Iterum Stock
0.86 | SNY | Sanofi ADR | PairCorr |
0.84 | AZN | AstraZeneca PLC ADR | PairCorr |
0.77 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
0.65 | PLX | Protalix Biotherapeutics | PairCorr |
0.65 | GOSS | Gossamer Bio | PairCorr |
0.64 | LLY | Eli Lilly | PairCorr |
0.58 | OCX | OncoCyte Corp | PairCorr |
0.51 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.86 | AMGN | Amgen Inc | PairCorr |
0.78 | DRMAW | Dermata Therapeutics | PairCorr |
0.72 | CMPX | Compass Therapeutics | PairCorr |
0.62 | NVCT | Nuvectis Pharma | PairCorr |
0.45 | RVP | Retractable Technologies Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Iterum Stock performing well and Iterum Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Iterum Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ONTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ADIL | 3.51 | (0.53) | 0.00 | (0.74) | 0.00 | 5.80 | 31.98 | |||
DFFN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
AEZS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
TNXP | 11.50 | 0.79 | 0.04 | 0.24 | 15.35 | 33.49 | 110.72 | |||
FBIO | 2.62 | (0.04) | 0.00 | (0.30) | 0.00 | 5.19 | 22.19 | |||
EYEN | 6.82 | (1.85) | 0.00 | 3.61 | 0.00 | 16.56 | 65.21 | |||
OCUP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
GRTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CTXR | 3.97 | (0.63) | 0.00 | (4.38) | 0.00 | 7.56 | 27.03 |
Iterum Therapeutics Corporate Management
Sailaja MD | Chief Officer | Profile | |
Tom Loughman | Senior Operations | Profile | |
Steven MD | Senior Development | Profile | |
Louise Barrett | Senior Secretary | Profile | |
Michael MD | Strategic Director | Profile | |
Judith Matthews | Chief Officer | Profile |